Alterations in genes other than <i>EGFR/ALK/ROS1</i> in non-small cell lung cancer: trials and treatment options

Alterations in genes other than <i>EGFR/ALK/ROS1</i> in non-small cell lung cancer: trials and treatment options

During the last decade, we have seen tremendous progress in the therapy of lung cancer. Discovery of actionable mutations in <i>EGFR</i> and translocations in <i>ALK</i> and <i>ROS1</i> have identified subsets of patients with excellent tumor response to oral targ...

Full description

Bibliographic Details
Main Authors: Arpita Desai, Smitha P. Menon, Grace K. Dy
Format: Article
Language:English
Published: China Anti-Cancer Association 2016-03-01
Series:Cancer Biology & Medicine
Subjects:
RAS
RAF
MEK
receptor tyrosine kinases (RTK)
fibroblast growth factor receptor (FGFR)
non-small cell lung cance (NSCLC)
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/910

Internet

http://www.cancerbiomed.org/index.php/cocr/article/view/910

Similar Items